<div id="readability-page-1">01:55 PM EST, 12/22/2025 (MT Newswires) -- Health care stocks advanced Monday afternoon, with the NYSE Health Care Index up 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.6%.The iShares Biotechnology ETF (IBB) climbed 1.6%.In corporate news, Abivax ( ABVX ) shares jumped past 16% after La Lettre reported that Eli Lilly ( LLY ) has entered early talks with French authorities to explore a possible acquisition of the biotech firm, according to a Google translated text of the report. Eli Lilly ( LLY ) shares were down 0.3%.Johnson &amp; Johnson ( JNJ ) shares added 0.6% after it said the European Commission has extended the marketing authorization for Tremfya, or guselkumab, as a subcutaneous treatment for moderate to severe pediatric plaque psoriasis.Zenas BioPharma ( ZBIO ) shares are seen as attractive ahead of the phase 3 top-line results for obexelimab, expected in the week of Jan. 5 for the treatment of IgG4-RD autoimmune disease, Wedbush said in a report. Zenas shares climbed nearly 16%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

ABVX

強生

禮來

醫療業 ETF - SPDR

醫療股上漲，紐約證券交易所醫療保健指數上漲 0.5%，XLV ETF 上漲 0.6%。Abivax 的股價在與禮來進行收購談判的消息中飆升超過 16%，而禮來的股價下跌 0.3%。強生的股價在歐盟批准 Tremfya 後上漲 0.6%。Zenas BioPharma 的股價在 Wedbush 提到 obexelimab 的三期結果即將公佈前上漲近 16%

板塊更新：醫療保健類股票在下午交易時段走高